Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

COL25A1 and METAP1D DNA methylation are promising liquid biopsy epigenetic biomarkers of colorectal cancer using digital PCR

18 Oct 2024

Abstract excerpt

BACKGROUND: Colorectal cancer is a public health issue and was the third leading cause of cancer-related death worldwide in 2022. Early diagnosis can improve prognosis, making screening a central part of colorectal cancer management. Blood-based screening, diagnosis and follow-up of colorectal cancer patients are possible with the study of cell-free circulating tumor DNA. This study aimed to identify novel DNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39425144
DOI: 10.1186/s13148-024-01748-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

COL25A1 and METAP1D DNA methylation are promising liquid biopsy epigenetic biomarkers of colorectal cancer using digital PCRPMID 39425144Read ↗

Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer—a clinical biomarker discovery and validation studySemantic proximity Read ↗

DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicineSemantic proximity Read ↗

Genome-Scale Discovery of DNA-Methylation Biomarkers for Blood-Based Detection of Colorectal CancerSemantic proximity Read ↗

Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.Semantic proximity Read ↗

Integration of multiomics features for blood-based early detection of colorectal cancer.Semantic proximity Read ↗

DNA Methylation-Based Testing in Peripheral Blood Mononuclear Cells Enables Accurate and Early Detection of Colorectal CancerSemantic proximity Read ↗

Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literatureSemantic proximity Read ↗

Identification of multi-omic biomarkers from Fecal DNA for improved Detection of Colorectal Cancer and precancerous lesionsSemantic proximity Read ↗

Efficacy of cell-free DNA methylation-based blood test for colorectal cancer screening in high-risk population: a prospective cohort studySemantic proximity Read ↗

Clinical Applications of DNA Methylation Biomarkers in Colorectal CancerSemantic proximity Read ↗

Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and predictionSemantic proximity Read ↗

Quantification method of ctDNA using cell-free DNA methylation profile for noninvasive screening and monitoring of colon cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.